Vimal Mehta
2021
In 2021, Vimal Mehta earned a total compensation of $9.4M as Chief Executive Officer and President at BioXcel Therapeutics, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $483,052 |
|---|---|
| Option Awards | $7,964,625 |
| Salary | $916,701 |
| Other | $7,800 |
| Total | $9,372,177 |
Mehta received $8M in option awards, accounting for 85% of the total pay in 2021.
Mehta also received $483.1K in non-equity incentive plan, $916.7K in salary and $7.8K in other compensation.
Rankings
In 2021, Vimal Mehta's compensation ranked 1,155th out of 12,415 executives tracked by ExecPay. In other words, Mehta earned more than 90.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,155 out of 12,415 | 91st |
Division Manufacturing | 406 out of 5,508 | 93rd |
Major group Chemicals And Allied Products | 147 out of 2,378 | 94th |
Industry group Drugs | 123 out of 2,099 | 94th |
Industry Pharmaceutical Preparations | 82 out of 1,549 | 95th |
Source: SEC filing on April 5, 2022.
Mehta's colleagues
We found three more compensation records of executives who worked with Vimal Mehta at BioXcel Therapeutics in 2021.
News
BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
April 29, 2024
BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
May 17, 2023
BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
April 5, 2022
BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
April 27, 2021
BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
April 6, 2020
BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
April 1, 2019